Cassava Sciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. It has one business segment: the development of novel drugs and diagnostics.
Frequently asked questions
To buy Cassava Sciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cassava Sciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cassava Sciences Inc. is SAVA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cassava Sciences Inc. has its primary listing on NASDAQ. You can trade Cassava Sciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cassava Sciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cassava Sciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cassava Sciences Inc..